InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by Ashar Bhavesh, Directeur Commercial. Director active across 2 companies, notably SpringWorks Therapeutics, Inc.. In total, 13 filings have been published. Split: 0 buy · 2 sells. Total volume traded: €103k. History available since 1 April 2022. The latest transaction was filed on 20 February 2025 (Cession). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Ashar Bhavesh
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations13 total
62,053 sharesCommon StockSEC:0001104659-25-065307:0
1,016 shares@ US$61.18918.7% of flowCommon StockSEC:0001104659-25-016615:0
17,323 shares0Common StockSEC:0001104659-25-003459:0
4,475 shares@ US$38.1924.3% of flowCommon StockSEC:0001104659-25-001778:0
3,825 shares@ US$38.1920.7% of flowCommon StockSEC:0001104659-25-001778:1
2,284 shares@ US$38.8612.6% of flowCommon StockSEC:0001104659-25-001778:2
1,824 shares@ US$47.6211.8% of flowCommon StockSEC:0001104659-24-043083:0
1,089 shares@ US$43.74656.4% of flowCommon StockSEC:0001104659-24-010827:0
26,445 shares0Common StockSEC:0001104659-24-002371:0
1,375 shares@ US$25.254.6% of flowCommon StockSEC:0001104659-23-042209:0
22,663 sharesCommon StockSEC:0001104659-23-002313:0
1,464 shares@ US$56.9011.0% of flowCommon StockSEC:0001104659-22-108477:0
13,062 sharesCommon StockSEC:0001104659-22-002740:0
13 of 13 declarations
About Ashar Bhavesh
Bhavesh Ashar is the Chief Commercial Officer at SpringWorks Therapeutics, Inc. He is responsible for the commercial strategy and sales growth of the company. With a strong background in the biopharmaceutical sector, Ashar plays a key role in business expansion and achieving commercial objectives.
